Aziyo Biologics Inc - Ordinary Shares - Class A Forecast, price target & analysts
Aziyo Biologics Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Aziyo Biologics Inc - Ordinary Shares - Class A Classifications & Recommendation:
Aziyo Biologics Inc - Ordinary Shares - Class A Price Target
| Target Price | $9.00 |
| Price | $2.46 |
| Potential |
265.85%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Aziyo Biologics Inc - Ordinary Shares - Class A 2026 .
The average Aziyo Biologics Inc - Ordinary Shares - Class A target price is $9.00.
This is
265.85%
register free of charge
$10.00
306.50%
register free of charge
$8.00
225.20%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend Aziyo Biologics Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Aziyo Biologics Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
265.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 24.38 | 33.30 |
| 1.49% | 36.59% | |
| EBITDA Margin | -85.44% | -38.74% |
| 24.17% | 54.66% | |
| Net Margin | -268.62% | -81.42% |
| 21.32% | 69.69% |
2 Analysts have issued a sales forecast Aziyo Biologics Inc - Ordinary Shares - Class A 2025 . The average Aziyo Biologics Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Aziyo Biologics Inc - Ordinary Shares - Class A 2025 . The average Aziyo Biologics Inc - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Aziyo Biologics Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Aziyo Biologics Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.86 | -0.77 |
| 22.50% | 58.60% | |
| P/E | negative | |
| EV/Sales | 3.81 |
2 Analysts have issued a Aziyo Biologics Inc - Ordinary Shares - Class A forecast for earnings per share. The average Aziyo Biologics Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Aziyo Biologics Inc - Ordinary Shares - Class A...
Current Aziyo Biologics Inc - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Nov 15 2024 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 06 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
